SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by King, D. J.
Right arrow Articles by BAP Consensus Group
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, D. J.
Right arrow Articles by BAP Consensus Group,
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Clinical Trials
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Other

Guidelines for the Use of Antipsychotic Drug Studies in Healthy Volunteers

David J. King

Department of Therapeutics and Pharmacology, The Queen's University of Belfast, The Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, UK

BAP Consensus Group

Department of Therapeutics and Pharmacology, The Queen's University of Belfast, The Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, UK

The following article summarizes the background to a British Association for Psychopharmacology Workshop held at the Royal Society, London, on 15 March 1996. It includes abstracts of the papers presented at that meeting and concludes with a list of agreed guidelines for future studies with antipsychotic drugs in healthy volunteer subjects.

Journal of Psychopharmacology, Vol. 11, No. 3, 201-208 (1997)
DOI: 10.1177/026988119701100302
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
D. McCartan, R. Bell, J. F. Green, C. Campbell, K. Trimble, A. Pickering, and D. J. King
The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers
J Psychopharmacol, March 1, 2001; 15(2): 96 - 104.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
V. Kumari, P. A. Cotter, O. F. Mulligan, S. A. Checkley, N. S. Gray, D. R. Hemsley, J. C. Thornton, P. J. Corr, B. K. Toone, and J. A. Gray
effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers
J Psychopharmacol, July 1, 1999; 13(4): 398 - 405.
[Abstract] [PDF]


Advertisement